Elevation of Blood Plasminogen Activator Inhibitor Level in Patients With Cerebral Venous Thrombosis

Suzan Bindal, Ozlem Coskun, Bulent Alioglu, Levent E. Inan, Burc Esra Sahin, Ruhsen Ocal

Abstract


Background: Cerebral venous thrombosis (CVT) accounts for 0.5% of cerebrovascular diseases (CVDs). A prothrombotic state can be demonstrated in 34% of the affected patients, while 22% of them had a genetic prothrombotic tendency. The main action of plasminogen activator inhibitor (PAI-1) is to regulate the fibrinolytic system. PAI-1 deficiency is associated with abnormal bleeding.

Methods: A total of 20 patients were confirmed to have CVT with brain magnetic resonance imaging (MRI) and MR venography, and 26 healthy controls were enrolled in this prospective study.

Results: PAI levels were studied in 20 patients who sustained a CVT attack and 26 healthy controls. PAI-1 levels were compared between patients with acute and chronic CVT as well. The mean PAI-1 levels in the healthy controls and patient group were 13.32 (4.58 - 47.72) and 40.66 (8.75 - 146.88), respectively. There was a significant difference between both groups with respect to PAI-1 level, with the patient group having a higher PAI-1 level. No significant differences in blood PAI-1 levels were found between acute and chronic CVT.

Conclusions: Our study demonstrated that PAI-1 level is a significant risk factor for acute and chronic CVT. In future, reducing PAI-1 levels may determine the treatment approach in CVT patients.




J Neurol Res. 2018;8(1-2):4-9
doi: https://doi.org/10.14740/jnr472w

 


Keywords


Sinus vein thrombosis; Plasminogen activator inhibitor; Cerebrovascular diseases; Fibrinolytic system

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Neurology Research, bimonthly, ISSN 1923-2845 (print), 1923-2853 (online), published by Elmer Press Inc.     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.neurores.org   editorial contact: editor@neurores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

DECLARATION: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!